Mobile Menu

Generic Pharmaceutical Manufacturing in Delaware

Author.Name IBISWorld United States Last Updated: August 2025 NAICS DE32541b

Generic Pharmaceutical Manufacturing in Delaware industry analysis

The Generic Pharmaceutical Manufacturing industry in Delaware is expected to decline an annualized -x.x% to $x.x million over the five years to 2025, while the national industry will likely decline at -x.x% during the same period. Industry establishments decreased an annualized -x.x% to x locations. Industry employment has decreased an annualized -x.x% to xxx workers, while industry wages have decreased an annualized -x.x% to $x.x million.

Over the five years to 2030, the industry is expected to decline an annualized -x.x% to $x.x million, while the national industry is expected to decline -x.x%. Industry establishments are forecast to stagnate x% to x locations. Industry employment is expected to decrease an annualized -x.x% to xxx workers, while industry wages are forecast to decrease -x% to $x.x million.

Unbiased research for even more industries at your fingertips

  • 5000+Industries covered
  • 100+Local analysts
  • 250k+Hours of detailed analysis
  • 100k+Subscriber community

Purchase a membership to access this industry and so much more.

About the Generic Pharmaceutical Manufacturing in Delaware Market Research Report

What’s Included in the Generic Pharmaceutical Manufacturing in Delaware Market Research Report

Definition of the Generic Pharmaceutical Manufacturing in Delaware?

Generic pharmaceutical manufacturers produce medications that are bioequivalent to brand name drugs that regulatory agencies have already approved. Generic manufacturers create drugs that contain the same active ingredients, dosage form, strength and intended use as the original brand name drugs.

What’s included in the Generic Pharmaceutical Manufacturing in Delaware?

The Generic Pharmaceutical Manufacturing in Delaware includes developing and producing generic drugs, marketing and distributing generic drugs and gaining regulatory approval for generic drugs. Related terms covered in the Generic Pharmaceutical Manufacturing in Delaware industry report includes a prescription drug produced by brand pharmaceutical companies and marketed under a private label at a generic product price, a large protein molecule derived from living sources, as opposed to a chemical substance. examples include insulin, human growth hormones and antibiotics, a drug derived from living organisms and marketed after the patent expiration of similar therapies. also known as flow-on biologics or biogenerics, an application filed for the approval of a new drug product. once approved, the product may be marketed in the united states and the period when numerous patents on blockbuster drugs are set to expire.

Industry Performance of the Generic Pharmaceutical Manufacturing industry in Delaware

Benchmark the Generic Pharmaceutical Manufacturing in Delaware industry performance with all DE county and national performance.

Generic Pharmaceutical Manufacturing in Delaware

#30 in Highest Revenue 0.3% of state's GDP
Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

Generic Pharmaceutical Manufacturing in the US


Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

For the full list of industry drivers, see report purchase options.

Key Drivers of the Generic Pharmaceutical Manufacturing industry in Delaware

See how key industry drivers, such as population, new business formation, per capita disposable income, total health expenditure, federal funding for medicare and medicaid and number of adults aged 65 and older are impacting Generic Pharmaceutical Manufacturing in Delaware

Delaware Economic Indicators

Population
New Business Formation
Per Capita Disposable Income

View more economic information in DE State Economic profile

US Key External Drivers

Total health expenditure
Federal funding for Medicare and Medicaid
Number of adults aged 65 and older

For the full list of industry drivers, see report purchase options.

County Data of the Generic Pharmaceutical Manufacturing industry in Delaware

Access proprietary data on county in the Generic Pharmaceutical Manufacturing in Delaware, such as New Castle County, Sussex County and Kent County. Data includes figures on revenue, establishments, employees and wages by counties.

Key Statistics of the Generic Pharmaceutical Manufacturing industry in Delaware

Download 18 years of historical data and 5 years of projected performance.

Need a deeper insight?
Get a free tour.

Free Tour

Top Questions Answered in this Report

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Generic Pharmaceutical Manufacturing industry in Delaware in 2025?

The market size of the Generic Pharmaceutical Manufacturing industry in Delaware is $113.8m in 2025.

How many businesses are there in the Generic Pharmaceutical Manufacturing industry in Delaware in 2025?

There are 4 businesses in the Generic Pharmaceutical Manufacturing industry in Delaware, which has been declining at an average annual rate of -4.4% from 2020 to 2025.

Has the Generic Pharmaceutical Manufacturing industry in Delaware grown or declined over the past 5 years?

The market size of the Generic Pharmaceutical Manufacturing industry in Delaware has been declining at an average annual rate of -5.9% from 2020 to 2025.

How many employees in the Generic Pharmaceutical Manufacturing industry in Delaware in 2025?

There are 177 employees in the Generic Pharmaceutical Manufacturing industry in Delaware, which has been declining at an average annual rate of -8.1% from 2020 to 2025.